Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fong Lok

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
The New England Journal of Medicine|July 1, 2005
The maze of treatments for hepatitis BAnna Suk-Fong Lok
Journal of Gastroenterology and Hepatology|November 13, 2010
Does antiviral therapy for hepatitis B and C prevent hepatocellular carcinoma?Anna Suk-Fong Lok
Nature Reviews. Gastroenterology & Hepatology|January 30, 2013
Hepatitis: Long-term therapy of chronic hepatitis B reverses cirrhosisAnna Suk-Fong Lok
Journal of Hepatology|September 18, 2009
EASL International Recognition Awardee 2009: Prof. Ding-Shinn ChenAnna Suk-Fong Lok
Gastroenterology|April 6, 2007
Navigating the maze of hepatitis B treatmentsAnna Suk-Fong Lok
Clinics in Liver Disease|November 27, 2012
HCV NS5A inhibitors in developmentAnna Suk-Fong Lok
Hepatology (Baltimore, Md.)|March 13, 2014
Progress in hepatitis B: a 30-year journey through three continentsAnna Suk-Fong Lok
Hepatology Communications|January 9, 2019
Hepatitis B Treatment: What We Know Now and What Remains to Be ResearchedAnna Suk-Fong Lok
Hepatology (Baltimore, Md.)|February 21, 2013
Combination nucleos(t)ide analogue as initial treatment for chronic hepatitis B: have we put this to rest?Anna Suk-Fong Lok
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 14, 2020
Is Sustained Virologic Response to Direct-acting Antivirals a Valid Surrogate Endpoint for Clinical Outcomes of Hepatitis C?Anna Suk-Fong Lok
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
The New England Journal of Medicine|July 1, 2005
The maze of treatments for hepatitis BAnna Suk-Fong Lok
Journal of Gastroenterology and Hepatology|November 13, 2010
Does antiviral therapy for hepatitis B and C prevent hepatocellular carcinoma?Anna Suk-Fong Lok
Nature Reviews. Gastroenterology & Hepatology|January 30, 2013
Hepatitis: Long-term therapy of chronic hepatitis B reverses cirrhosisAnna Suk-Fong Lok
Journal of Hepatology|September 18, 2009
EASL International Recognition Awardee 2009: Prof. Ding-Shinn ChenAnna Suk-Fong Lok
Gastroenterology|April 6, 2007
Navigating the maze of hepatitis B treatmentsAnna Suk-Fong Lok
Clinics in Liver Disease|November 27, 2012
HCV NS5A inhibitors in developmentAnna Suk-Fong Lok
Hepatology (Baltimore, Md.)|March 13, 2014
Progress in hepatitis B: a 30-year journey through three continentsAnna Suk-Fong Lok
Hepatology Communications|January 9, 2019
Hepatitis B Treatment: What We Know Now and What Remains to Be ResearchedAnna Suk-Fong Lok
Hepatology (Baltimore, Md.)|February 21, 2013
Combination nucleos(t)ide analogue as initial treatment for chronic hepatitis B: have we put this to rest?Anna Suk-Fong Lok
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 14, 2020
Is Sustained Virologic Response to Direct-acting Antivirals a Valid Surrogate Endpoint for Clinical Outcomes of Hepatitis C?Anna Suk-Fong Lok
Pageof 3